Withings Scan Monitor vs ElucidVivo A.3

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Withings
VS
by Elucid

AI Verdict

Tool A, Withings Scan Monitor, is designed for remote patient monitoring and early detection of cardiac events and vital signs through personal smart devices. In contrast, Tool B, ElucidVivo A.3, specializes in advanced AI-powered analysis of CT angiography images to quantify arterial plaque composition for atherosclerosis patient stratification. While both contribute to cardiovascular health, they address distinct stages of care and utilize different data sources and deployment models.

Choose Withings Scan Monitor if…

Choose Withings Scan Monitor if you need a user-friendly, device-based solution for continuous personal health monitoring and early detection of cardiovascular irregularities at home. It is ideal for individuals seeking to proactively track their heart health, body composition, and other vital metrics, or for healthcare providers implementing remote patient monitoring programs for general wellness and early AFib detection.

View Withings Scan Monitor →

Choose ElucidVivo A.3 if…

Choose ElucidVivo A.3 if you are a clinician requiring advanced, AI-powered quantitative analysis of arterial plaque composition from CT angiography to inform critical treatment decisions for atherosclerosis patients. This tool is best suited for detailed diagnostic assessment, patient stratification, and optimizing interventions based on precise plaque characteristics and stability.

View ElucidVivo A.3 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Withings Scan Monitor ElucidVivo A.3
Pricing Device purchase with optional subscription for enhanced features and clinical services. Unknown
Deployment Device-based (smart scale, smartwatch) with cloud synchronization and mobile application. Cloud and on-premise secure deployment.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Withings Scan Monitor

Withings Scan Monitor (Tool A) is integrated into consumer-friendly smart scales and smartwatches with a mobile application, making it highly accessible for personal use and remote patient monitoring. ElucidVivo A.3 (Tool B) is a specialized medical image analysis system designed for clinicians, requiring integration into complex PACS/EMR workflows, which implies a more specialized and less broadly 'usable' interface for the general public.

Clinical Value

ElucidVivo A.3

ElucidVivo A.3 (Tool B) offers highly specialized and validated quantitative analysis of arterial plaque composition from CT angiography, aiding in atherosclerosis patient stratification and treatment optimization, with validation against histology. Withings Scan Monitor (Tool A) provides valuable general health metrics and AFib detection, but Tool B's deep diagnostic capabilities for a critical cardiovascular condition represent a more profound and specialized clinical impact.

Pricing & Value

Withings Scan Monitor

Withings Scan Monitor (Tool A) has transparent pricing with a clear device purchase cost and an optional monthly subscription, making its value proposition easily understandable and accessible to consumers and smaller professional setups. ElucidVivo A.3 (Tool B) requires contacting for pricing, which typically indicates a higher, enterprise-level cost that is not publicly disclosed, making its immediate value assessment less transparent.

Enterprise Readiness

ElucidVivo A.3

ElucidVivo A.3 (Tool B) is an FDA-cleared medical image analysis system designed for integration with PACS/EMR systems, which is fundamental for enterprise clinical workflows in radiology and cardiology departments. While Withings Scan Monitor (Tool A) supports remote patient monitoring, its primary deployment is device-based for consumers, making Tool B inherently more aligned with traditional enterprise healthcare IT infrastructure and integration requirements.

Innovation

ElucidVivo A.3

ElucidVivo A.3 (Tool B) demonstrates significant innovation by providing AI-powered quantitative analysis of arterial plaque composition and stability from CT images, validated against ground-truth histology, which offers unprecedented insights for atherosclerosis management. Withings Scan Monitor (Tool A) innovates by integrating multiple advanced health metrics into accessible consumer devices, but Tool B's specialized diagnostic breakthrough in medical imaging for a complex disease is arguably more groundbreaking in a clinical context.

Support & Docs

ElucidVivo A.3

Withings Scan Monitor (Tool A) offers consumer-grade support, including FAQs, user guides, and chat, suitable for individual users and basic professional use. ElucidVivo A.3 (Tool B), as an enterprise medical imaging solution, requires and likely provides more comprehensive technical support, training, and in-depth documentation tailored for clinical IT departments and medical professionals, which is critical for complex hospital deployments and ongoing clinical use.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Withings Scan Monitor ElucidVivo A.3
Name Withings Scan Monitor ElucidVivo A.3
Company Withings Elucid Bioimaging
Description AI-powered tool integrated into smart scales and smartwatches, offering FDA-cleared ECG for AFib detection, heart rate, and other vital health metrics for both personal use and professional remote patient monitoring. FDA-cleared AI-powered medical image analysis system that provides quantitative analysis of arterial plaque composition and stability from CT angiography. It assists physicians in atherosclerosis patient stratification and optimizes treatment decisions by offering detailed visualization and measurement of plaque characteristics validated against histology.
Key Features 6-lead ECG for Atrial Fibrillation (AFib) detection (Body Scan), Single-lead ECG for Atrial Fibrillation (AFib) detection (ScanWatch), Heart rate measurement and irregular rhythm notifications, Blood oxygen saturation (SpO2) measurement (ScanWatch), Vascular Age assessment (Body Scan), Nerve Health Score (Electrodermal Activity) (Body Scan), Segmental body composition analysis (Body Scan), Automatic data synchronization via Wi-Fi and Bluetooth. AI-powered quantitative analysis of arterial plaque, Objectively quantifies Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images, Visualizes lesion-level plaque composition, Provides 3D visualization of highlighted vessels, Offers rotatable curved MPR vessel views and cross-sections, Aids in stratifying patients with atherosclerosis, Derives fractional flow reserve (FFRct) based on vessel wall vasodilative capacity, Validated on ground-truth histology.
Categories Cardiology AI, Wearables & Remote Monitoring (RPM) Cardiology AI, Radiology & Imaging AI
Specialties Cardiology, Internal Medicine Cardiology, Radiology, Vascular Surgery

Videos

Demos, reviews, and walkthroughs featuring Withings Scan Monitor and ElucidVivo A.3.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Withings Scan Monitor, being device-based, integrates by providing automated data synchronization of vital health metrics to a mobile application and cloud, supporting remote patient monitoring and patient self-management. ElucidVivo A.3, as a software application, integrates with PACS/EMR systems to process CT angiography images, offering quantitative plaque analysis to assist physicians in atherosclerosis patient stratification and treatment optimization.
Withings Scan Monitor's ECG for AFib detection has been clinically validated, demonstrating high sensitivity and specificity in studies, though some recordings may be inconclusive. Its SpO2 measurements also show adequate clinical accuracy. ElucidVivo A.3 provides quantitative analysis of arterial plaque composition and stability from CT images, which has been validated against histology.
Withings Scan Monitor is best suited for Cardiology and Internal Medicine, focusing on general cardiovascular health, AFib detection, and overall wellness monitoring for a broad patient population. ElucidVivo A.3 is designed for Cardiology, Radiology, and Vascular Surgery, providing advanced atherosclerosis assessment and treatment decision optimization for patients with known or suspected cardiovascular disease.
The Withings Scan Monitor likely has a low learning curve for patients using the devices and a moderate curve for physicians interpreting data from the associated app or platform. ElucidVivo A.3 would likely involve a moderate learning curve for physicians and staff to navigate the software interface, interpret detailed plaque analysis, and integrate FFRct into clinical decisions.
For Withings Scan Monitor, multi-site rollout involves distributing individual devices to patients, onboarding them, and aggregating data for physician review, potentially through an RPM platform. ElucidVivo A.3's implementation would focus on software deployment, IT integration with existing PACS/EMR systems, and training staff across multiple imaging centers or hospitals.

Backers

Who funded each tool's parent company.

Withings Scan Monitor

AI Tool Finder
AI-powered search. Results may not be comprehensive.